Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT03473392 Completed - Clinical trials for Prosthetic Joint Infection

One-stage Exchange Arthroplasty for Chronic Prosthetic Joint Infections

Start date: April 2016
Phase:
Study type: Observational

The results found in the literature do not allow to define objectively the indications respective for a one-step or a two-step exchange of prosthetic joint. Some criteria could help to decide for one-step exchange or two-step exchange: bacteria is/are identified, profile of the bacteria, anesthetic difficulties,.. A puncture could allow to identify the bacteria involved in the prosthetic joint infection (PJI) and an antibiotherapy for a few days can be given to the patient in order to decrease the inoculum. Then, a one-step exchange can be performed. The purpose of this study is to describe the management of patients who had a pre-treatment before a one-step exchange of their prosthetic joint.

NCT ID: NCT03469063 Recruiting - Quality of Life Clinical Trials

Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients

AFERBIO
Start date: June 28, 2018
Phase: N/A
Study type: Interventional

The AFERBIO study will evaluates safety and potential benefit of AferBio® in patients with non-small cell lung cancer undergoing at least a second-line palliative monochemotherapy. AferBio® is a fermented supplement in powder form obtained through biotechnological processes developed in Brazil. In this double-blind placebo-controlled randomized clinical trial, participants starting a new palliative regimen will be allocated to AferBio® or placebo. The primary aim will be to compare health-related QOL scores among the arms of the study over time.

NCT ID: NCT03468933 Completed - Pleural Diseases Clinical Trials

Fibrinolysis Compared to Thoracoscopy for Pleural Infection

Start date: November 1, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management of empyema or complicated parapneumonic effusion (CPPE) in adults.

NCT ID: NCT03468829 Withdrawn - Clinical trials for Respiratory Syncytial Virus Lower Respiratory Tract Infection

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Start date: February 2019
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to evaluate the antiviral effect and safety of inhaled ALX-0171 in adults diagnosed with respiratory syncytial virus (RSV) respiratory tract infection after hematopoietic stem cell transplantation (HSCT). The secondary objective is to assess the clinical activity, pharmacokinetics (PK), virology, and immunogenicity of inhaled ALX 0171 in adults diagnosed with RSV respiratory tract infection after HSCT.

NCT ID: NCT03468114 Completed - Diarrhea Clinical Trials

The Safe Start Trial - Kisumu, Kenya

Start date: March 26, 2018
Phase: N/A
Study type: Interventional

This a cluster randomised controlled trial (cRCT) to evaluate the effect of a novel food hygiene intervention on infant health.

NCT ID: NCT03466489 Withdrawn - Clinical trials for Surgical Site Infection

Floraseal Versus Iodine Impregnated Adhesive Drapes

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Infection after total joint arthroplasty can have devastating consequences. Adhesive drapes have been traditionally used at our institution to help reduce the risk of wound contamination and infection by superficial skin flora. Our primary objective is to determine if a cyanoacrylate-based sealant (FloraSeal microbial sealant) is superior to conventional iodine impregnated drapes in prevention of both superficial and deep surgical site infections in total joint arthroplasty (TJA) patients. A prospective, randomized controlled model will be used to answer this question.

NCT ID: NCT03464279 Completed - Antibiotics Clinical Trials

Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections

Start date: May 29, 2015
Phase: N/A
Study type: Interventional

In an effort to implement Choosing Wisely guidelines and decrease patient harm, we will implement and evaluate a clinician audit-feedback and behavioral "nudge" initiative to reduce low-value antibiotics for URIs. Using a quasi-experiment (pre-post) design, antibiotic prescriptions for URI at LAC+USC Urgent Care Center (intervention site) vs. Olive View-UCLA Urgent Care Center (control site) will used to test the effects of behavioral "nudge" on antibiotic prescribing.

NCT ID: NCT03462160 Not yet recruiting - Clinical trials for Prevention of Urinary Tract Infections in Children

Effectiveness of Probiotics Prophylaxis of Urinary Tract Infections in Children

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The investigators aim to assess the effectiveness of prophylaxis of urinary tract infections in children with a probiotic containing Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1. It is formulated a hypothesis that a 3-months course of probiotic prophylasis is more effective than placebo.

NCT ID: NCT03460392 Enrolling by invitation - Clinical trials for Microbial Colonization

Study of Human Microbiota in Healthy and Pathological Conditions

MicroSP
Start date: June 12, 2017
Phase: N/A
Study type: Observational [Patient Registry]

The aim of the present study is to characterize the bacterial composition (microbiota) colonizing to the human body in different physio - pathological conditions (lifestyle, motor activity, surgical operations, probiotic and prebiotic consumption, antibiotic therapies, chemotherapeutic therapies), nervous and musculoskeletal diseases, gastrointestinal and metabolic disorders , oral and vaginal diseases, etc.). In particular, they will be investigate: - the changes in the bacterial abundance - the potential microbial interactions with the human host - the microbial networks describing on the bacterial interactions within a specific composition of the human microbiota

NCT ID: NCT03460262 Not yet recruiting - Infection Wound Clinical Trials

Negative Pressure Wound Therapy for Prevention of Groin Infection Following Vascular Surgery

PICO
Start date: March 15, 2018
Phase: N/A
Study type: Interventional

Surgical site infection in vascular surgery is a relatively common event with reported incidence as high as 43%. When considering the groin alone, the incidence is around 20% (30% when considering any wound complication). This complication may sometimes lead to heavier complication (leg amputation, longer hospital stay, high costs…) and affects the early postoperative quality of life of the patients.